Drug Shortage Report for BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Report ID | 146732 |
Drug Identification Number | 00037818 |
Brand name | BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP |
Common or Proper name | BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 x 30mL vial |
ATC code | B05CB |
ATC description | IRRIGATING SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | |
Actual end date | 2023-11-08 |
Shortage status | Resolved |
Updated date | 2023-11-09 |
Company comments | 10mL format remains available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.